Recombinant activated factor VII for acute intracerebral hemorrhage.
This is an extremely important, long-awaited study on the effect of rFVIIa in management of intracerebral haemorrhage. It is a double-blind, placebo-controlled study which enrolled 399 patients into control placebo […]
Stopping the bleeding in intracerebral hemorrhage. [Editorial]
This editorial reviews the work of Mayer et al. on the use of rFVIIa in patients who suffer intracerebral hemorrhage and gives a new hope of therapy which can prevent […]